Client News
Filter by:
- Nov 16 2021 INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster Clinical Trial of its Ebola DNA Vaccine Candidate, INO-4201
- Nov 15 2021 INOVIO to Give Eight Presentations at the 34th International Papillomavirus Conference
- Nov 9 2021 INOVIO Reports Third Quarter 2021 Financial Results
- Nov 2 2021 OncoSec Medical Hosting SITC Key Opinion Leader Webinar on Updated Data from the KEYNOTE-695 Study
- Nov 1 2021 Arch Therapeutics Presents AC5® Advanced Wound System During Innovation Spotlight at 2021 Symposium on Advanced Wound Care (SAWC)
- Oct 20 2021 OncoSec Provides Business Update
- Sep 21 2021 AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today
- Sep 14 2021 AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma
- Sep 13 2021 AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications
- Sep 10 2021 AzurRx BioPharma Announces Reverse Stock Split